A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, WITHDRAWAL, SAFETY AND EFFICACY STUDY OF ORAL BARICITINIB IN PATIENTS FROM 1 YEAR TO LESS THAN 18 YEARS OLD WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA).
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ELI LILLY AND COMPANY
Portal de investigación